Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Melanoma × Radiotherapy × Clear all

Phase

Phase 2 12 Phase 1 7 Phase 1/2 5 Phase 3 4 Phase NA 1 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 35 Prostatic Neoplasms 25 Lymphoma 12 Carcinoma, Non-Small-Cell Lung 12 Head and Neck Neoplasms 11 Recurrence 10 Rectal Neoplasms 10 Neoplasms 9 Lung Neoplasms 9 Precursor Cell Lymphoblastic Leukemia-Lymphoma 7 Lymphoma, Non-Hodgkin 7 Lymphoma, Large B-Cell, Diffuse 7 Leukemia 7 Esophageal Squamous Cell Carcinoma 7 Central Nervous System Neoplasms 7 Uterine Cervical Neoplasms 6 Neoplasm Metastasis 6 Multiple Myeloma 6 Esophageal Neoplasms 6 Carcinoma, Hepatocellular 6 Squamous Cell Carcinoma of Head and Neck 5 Lymphoma, Follicular 5 Hyperthermia 5 Hodgkin Disease 5 Dendritic Cell Sarcoma, Interdigitating 5 Congenital Abnormalities 5 Carcinoma, Intraductal, Noninfiltrating 5 Burkitt Lymphoma 5 Sarcoma 4 Primary Myelofibrosis 4

Interventions

Blood Specimen Collection 11 Radiosurgery 7 Surveys and Questionnaires 4 Standard of Care 4 Practice Guidelines as Topic 4 Methods 4 Educational Status 4 Early Intervention, Educational 4 Surgical Procedures, Operative 3 Nivolumab 3 Ipilimumab 3 Indocyanine Green 3 Biopsy 3 pembrolizumab 2 aldesleukin 2 X-Rays 2 Tomography, X-Ray Computed 2 Sentinel Lymph Node Biopsy 2 Radiation 2 Magnetic Resonance Spectroscopy 2 Interleukin-2 2 Immunotherapy 2 Immunohistochemistry 2 Immune Checkpoint Inhibitors 2 Diathermy 2 Dermoscopy 2 Cyclophosphamide 2 Cognitive Behavioral Therapy 2 toripalimab 1 sargramostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00975520 2024-11-27

RTN2

Melanoma and Skin Cancer Trials Limited

Phase NA Completed

Melanoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡